Enhanced specificity mutations perturb allosteric signaling in CRISPR-Cas9

  1. Lukasz Nierzwicki
  2. Kyle W East
  3. Uriel N Morzan
  4. Pablo R Arantes
  5. Victor S Batista
  6. George P Lisi  Is a corresponding author
  7. Giulia Palermo  Is a corresponding author
  1. University of California, Riverside, United States
  2. Brown University, United States
  3. International Centre for Theoretical Physics, Italy
  4. Yale University, United States

Abstract

CRISPR-Cas9 is a molecular tool with transformative genome editing capabilities. At the molecular level, an intricate allosteric signaling is critical for DNA cleavage, but its role in the specificity enhancement of the Cas9 endonuclease is poorly understood. Here, multi-microsecond molecular dynamics is combined with solution NMR and graph theory-derived models to probe the allosteric role of key specificity-enhancing mutations. We show that mutations responsible for increasing the specificity of Cas9 alter the allosteric structure of the catalytic HNH domain, impacting the signal transmission from the DNA recognition region to the catalytic sites for cleavage. Specifically, the K855A mutation strongly disrupts the allosteric connectivity of the HNH domain, exerting the highest perturbation on the signaling transfer, while K810A and K848A result in more moderate effects on the allosteric communication. This differential perturbation of the allosteric signal correlates to the order of specificity enhancement (K855A > K848A ~ K810A) observed in biochemical studies, with the mutation achieving the highest specificity most strongly perturbing the signaling transfer. These findings suggest that alterations of the allosteric communication from DNA recognition to cleavage are critical to increasing the specificity of Cas9 and that allosteric hotspots can be targeted through mutational studies for improving the system's function.

Data availability

Analysis codes and script files can be downloaded from Github: https://github.com/palermolabResonance assignments for the HNH structure are available at bmrb.io under BMRB entry 27949.

Article and author information

Author details

  1. Lukasz Nierzwicki

    Department of Bioengineering, University of California, Riverside, Riverside, United States
    Competing interests
    The authors declare that no competing interests exist.
  2. Kyle W East

    Department of Molecular Biology, Cell Biology and Biochemistry, Brown University, Providence, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Uriel N Morzan

    International Centre for Theoretical Physics, Trieste, Italy
    Competing interests
    The authors declare that no competing interests exist.
  4. Pablo R Arantes

    Department of Bioengineering, University of California, Riverside, Riverside, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Victor S Batista

    Department of Chemistry, Yale University, New Heaven, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. George P Lisi

    Department of Molecular Biology, Cell Biology and Biochemistry, Brown University, Providence, United States
    For correspondence
    george_lisi@brown.edu
    Competing interests
    The authors declare that no competing interests exist.
  7. Giulia Palermo

    Department of Bioengineering, University of California, Riverside, Riverside, United States
    For correspondence
    giulia.palermo@ucr.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-1404-8737

Funding

National Institutes of Health (R01GM141329)

  • Giulia Palermo

National Science Foundation (CHE-1905374)

  • Giulia Palermo

National Institutes of Health (R01GM136815)

  • Victor S Batista
  • George P Lisi
  • Giulia Palermo

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Rina Rosenzweig, Weizmann Institute of Science, Israel

Version history

  1. Received: September 3, 2021
  2. Accepted: December 14, 2021
  3. Accepted Manuscript published: December 15, 2021 (version 1)
  4. Version of Record published: January 7, 2022 (version 2)

Copyright

© 2021, Nierzwicki et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,522
    views
  • 272
    downloads
  • 34
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Lukasz Nierzwicki
  2. Kyle W East
  3. Uriel N Morzan
  4. Pablo R Arantes
  5. Victor S Batista
  6. George P Lisi
  7. Giulia Palermo
(2021)
Enhanced specificity mutations perturb allosteric signaling in CRISPR-Cas9
eLife 10:e73601.
https://doi.org/10.7554/eLife.73601

Share this article

https://doi.org/10.7554/eLife.73601

Further reading

    1. Biochemistry and Chemical Biology
    2. Structural Biology and Molecular Biophysics
    Thomas RM Germe, Natassja G Bush ... Anthony Maxwell
    Research Article

    DNA gyrase, a ubiquitous bacterial enzyme, is a type IIA topoisomerase formed by heterotetramerisation of 2 GyrA subunits and 2 GyrB subunits, to form the active complex. DNA gyrase can loop DNA around the C-terminal domains (CTDs) of GyrA and pass one DNA duplex through a transient double-strand break (DSB) established in another duplex. This results in the conversion from a positive (+1) to a negative (–1) supercoil, thereby introducing negative supercoiling into the bacterial genome by steps of 2, an activity essential for DNA replication and transcription. The strong protein interface in the GyrA dimer must be broken to allow passage of the transported DNA segment and it is generally assumed that the interface is usually stable and only opens when DNA is transported, to prevent the introduction of deleterious DSBs in the genome. In this paper, we show that DNA gyrase can exchange its DNA-cleaving interfaces between two active heterotetramers. This so-called interface ‘swapping’ (IS) can occur within a few minutes in solution. We also show that bending of DNA by gyrase is essential for cleavage but not for DNA binding per se and favors IS. Interface swapping is also favored by DNA wrapping and an excess of GyrB. We suggest that proximity, promoted by GyrB oligomerization and binding and wrapping along a length of DNA, between two heterotetramers favors rapid interface swapping. This swapping does not require ATP, occurs in the presence of fluoroquinolones, and raises the possibility of non-homologous recombination solely through gyrase activity. The ability of gyrase to undergo interface swapping explains how gyrase heterodimers, containing a single active-site tyrosine, can carry out double-strand passage reactions and therefore suggests an alternative explanation to the recently proposed ‘swivelling’ mechanism for DNA gyrase (Gubaev et al., 2016).

    1. Biochemistry and Chemical Biology
    2. Structural Biology and Molecular Biophysics
    Marian Brenner, Christoph Zink ... Antje Gohla
    Research Article

    Vitamin B6 deficiency has been linked to cognitive impairment in human brain disorders for decades. Still, the molecular mechanisms linking vitamin B6 to these pathologies remain poorly understood, and whether vitamin B6 supplementation improves cognition is unclear as well. Pyridoxal 5’-phosphate phosphatase (PDXP), an enzyme that controls levels of pyridoxal 5’-phosphate (PLP), the co-enzymatically active form of vitamin B6, may represent an alternative therapeutic entry point into vitamin B6-associated pathologies. However, pharmacological PDXP inhibitors to test this concept are lacking. We now identify a PDXP and age-dependent decline of PLP levels in the murine hippocampus that provides a rationale for the development of PDXP inhibitors. Using a combination of small-molecule screening, protein crystallography, and biolayer interferometry, we discover, visualize, and analyze 7,8-dihydroxyflavone (7,8-DHF) as a direct and potent PDXP inhibitor. 7,8-DHF binds and reversibly inhibits PDXP with low micromolar affinity and sub-micromolar potency. In mouse hippocampal neurons, 7,8-DHF increases PLP in a PDXP-dependent manner. These findings validate PDXP as a druggable target. Of note, 7,8-DHF is a well-studied molecule in brain disorder models, although its mechanism of action is actively debated. Our discovery of 7,8-DHF as a PDXP inhibitor offers novel mechanistic insights into the controversy surrounding 7,8-DHF-mediated effects in the brain.